Discussion on the Status of the Recent FDA Warning Letter

IRadimed Corporation Announces Conference Call to Discuss the Status of the Recent FDA Warning Letter

IRADIMED CORPORATION (NASDAQ:IRMD), today announced that it will host a conference call on Thursday, September 18, 2014 beginning at 11:00 a.m. Eastern Time to provide an update on the Company's September 2nd press release regarding the receipt of a warning letter from the U.S. Food and Drug Administration ("FDA").

Individuals interested in listening to the conference call may do so by dialing 1-844-413-1781 for domestic callers, or 1-716-247-5767 for international callers, and entering reservation code 6026014.

The conference call will also be available real-time via the Internet at http://www.iradimed.com/en-us/investors/index.php and selecting Events & Presentations. A recording of the call will be available on the Company's website for 90 days following completion of the call.

On September 2, 2014, IRADIMED announced that it received a warning letter from the FDA relating to an inspection of the Company's facility that took place in April 2014. The Company has provided certain additional information relating to the matters set forth in their September 2nd press release, as well as a copy of the warning letter as an exhibit in a Current Report on Form 8-K filed with the Securities and Exchange Commission on September 3, 2014. Please refer to the Current Report on Form 8-K for more information.

Kevin Jirka